To ensure that consumers of regulated products were delivered with quality and safe products, the National Agency for Food and Drug Administration and Control(NAFDAC), has called on government agencies, the international community, regulatory bodies and other stakeholders in the regulatory sector to embrace effective regulation and collaboration in order to move the sector forward .
According to the Director-General of the agency, Dr. Paul Orhii, leveraging on collaborative efforts will definitely play a significant role in ensuring effective regulation.
Speaking during the 2nd NAFDAC Regulatory Forum in Lagos last week with the theme “Leveraging Collaborative Efforts To Ensure Effective Regulation”, Orhii said effective regulation was key to ensuring access to safe products of good quality.
Reeling out the benefits of effective collaboration, Orhii said adopting such approach would bring about increased regulatory capacity, improved regulatory infrastructure, private sector participation, confidence in the systems and also strengthen the regulatory processes.
He noted that the essence of control and regulation was to protect public health by ensuring that only quality regulated products that are safe, efficacious and wholesome reach the market, and ultimately the consuming public.
In her remarks, Director, Registration & Regulatory Affairs of NAFDAC, Dr. Monica Hemben Eimunjeze, said “We strongly believe that collaboration is a key element to ensure success in regulation and remain resolute in our commitment to build stronger local, regional and international networks.”
She noted: “Our collaborative efforts have resulted in considerable gains in our regulatory capacity both in terms of human capacity development and infrastructure. This has also impacted on the regulated sector with notable and remarkable achievements being made in the pharmaceutical industry as a result of positive engagements between NAFDAC, WHO, and the USP to mention a few.
Our collaboration with stakeholders groups such as the AFBTE and pharmaceutical companies such as Roche, Sanofi, L’Oreal and Novartis have resulted in shared training and resource which have boosted our capacity building efforts within the Agency and for other healthcare professionals.”
Also, Chairman, Pharmaceutical Manufacturers Group of Manufacturers Association of Nigeria, (PMG-MAN), Okey Akpa, said if the industry must grow, effective collaboration must be accorded priority.
According to him, it was effective collaboration that made four Nigerian pharmaceutical companies to get the World Heath Organization pre-qualification for their products, insisting that the measure has yielded unparallel result in the system.
For Fred Chiazor, Chairman, Technical Committee of the Association of Food Beverage and Tobacco Employers(AFBTE),regulations and responsibilities of those involved should be clearly spelt out and understood.
He identified multiple laws, overlapping functions of government agencies and multiple levies as challenges confronting effective regulation of products in Nigeria.